2022-06-012023-05-312023-05-31false06743271LIFETIME FINANCIAL THERAPY LIMITED2023-09-1482990iso4217:GBPxbrli:pure067432712022-06-01067432712023-05-31067432712022-06-012023-05-31067432712021-06-01067432712022-05-31067432712021-06-012022-05-3106743271bus:SmallEntities2022-06-012023-05-3106743271bus:AuditExempt-NoAccountantsReport2022-06-012023-05-3106743271bus:FullAccounts2022-06-012023-05-3106743271bus:PrivateLimitedCompanyLtd2022-06-012023-05-3106743271core:WithinOneYear2023-05-3106743271core:AfterOneYear2023-05-3106743271core:WithinOneYear2022-05-3106743271core:AfterOneYear2022-05-3106743271core:ShareCapital2023-05-3106743271core:SharePremium2023-05-3106743271core:RevaluationReserve2023-05-3106743271core:OtherReservesSubtotal2023-05-3106743271core:RetainedEarningsAccumulatedLosses2023-05-3106743271core:ShareCapital2022-05-3106743271core:SharePremium2022-05-3106743271core:RevaluationReserve2022-05-3106743271core:OtherReservesSubtotal2022-05-3106743271core:RetainedEarningsAccumulatedLosses2022-05-3106743271core:LandBuildings2023-05-3106743271core:PlantMachinery2023-05-3106743271core:Vehicles2023-05-3106743271core:FurnitureFittings2023-05-3106743271core:OfficeEquipment2023-05-3106743271core:NetGoodwill2023-05-3106743271core:IntangibleAssetsOtherThanGoodwill2023-05-3106743271core:ListedExchangeTraded2023-05-3106743271core:UnlistedNon-exchangeTraded2023-05-3106743271core:LandBuildings2022-05-3106743271core:PlantMachinery2022-05-3106743271core:Vehicles2022-05-3106743271core:FurnitureFittings2022-05-3106743271core:OfficeEquipment2022-05-3106743271core:NetGoodwill2022-05-3106743271core:IntangibleAssetsOtherThanGoodwill2022-05-3106743271core:ListedExchangeTraded2022-05-3106743271core:UnlistedNon-exchangeTraded2022-05-3106743271core:LandBuildings2022-06-012023-05-3106743271core:PlantMachinery2022-06-012023-05-3106743271core:Vehicles2022-06-012023-05-3106743271core:FurnitureFittings2022-06-012023-05-3106743271core:OfficeEquipment2022-06-012023-05-3106743271core:NetGoodwill2022-06-012023-05-3106743271core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3106743271core:ListedExchangeTraded2022-06-012023-05-3106743271core:UnlistedNon-exchangeTraded2022-06-012023-05-3106743271core:MoreThanFiveYears2022-06-012023-05-3106743271core:Non-currentFinancialInstruments2023-05-3106743271core:Non-currentFinancialInstruments2022-05-3106743271dpl:CostSales2022-06-012023-05-3106743271dpl:DistributionCosts2022-06-012023-05-3106743271dpl:AdministrativeExpenses2022-06-012023-05-3106743271core:LandBuildings2022-06-012023-05-3106743271core:PlantMachinery2022-06-012023-05-3106743271core:Vehicles2022-06-012023-05-3106743271core:FurnitureFittings2022-06-012023-05-3106743271core:OfficeEquipment2022-06-012023-05-3106743271core:NetGoodwill2022-06-012023-05-3106743271core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3106743271dpl:GroupUndertakings2022-06-012023-05-3106743271dpl:ParticipatingInterests2022-06-012023-05-3106743271dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3106743271core:ListedExchangeTraded2022-06-012023-05-3106743271dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3106743271core:UnlistedNon-exchangeTraded2022-06-012023-05-3106743271dpl:CostSales2021-06-012022-05-3106743271dpl:DistributionCosts2021-06-012022-05-3106743271dpl:AdministrativeExpenses2021-06-012022-05-3106743271core:LandBuildings2021-06-012022-05-3106743271core:PlantMachinery2021-06-012022-05-3106743271core:Vehicles2021-06-012022-05-3106743271core:FurnitureFittings2021-06-012022-05-3106743271core:OfficeEquipment2021-06-012022-05-3106743271core:NetGoodwill2021-06-012022-05-3106743271core:IntangibleAssetsOtherThanGoodwill2021-06-012022-05-3106743271dpl:GroupUndertakings2021-06-012022-05-3106743271dpl:ParticipatingInterests2021-06-012022-05-3106743271dpl:GroupUndertakingscore:ListedExchangeTraded2021-06-012022-05-3106743271core:ListedExchangeTraded2021-06-012022-05-3106743271dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-06-012022-05-3106743271core:UnlistedNon-exchangeTraded2021-06-012022-05-3106743271core:NetGoodwill2023-05-3106743271core:IntangibleAssetsOtherThanGoodwill2023-05-3106743271core:LandBuildings2023-05-3106743271core:PlantMachinery2023-05-3106743271core:Vehicles2023-05-3106743271core:FurnitureFittings2023-05-3106743271core:OfficeEquipment2023-05-3106743271core:AfterOneYear2023-05-3106743271core:WithinOneYear2023-05-3106743271core:ListedExchangeTraded2023-05-3106743271core:UnlistedNon-exchangeTraded2023-05-3106743271core:ShareCapital2023-05-3106743271core:SharePremium2023-05-3106743271core:RevaluationReserve2023-05-3106743271core:OtherReservesSubtotal2023-05-3106743271core:RetainedEarningsAccumulatedLosses2023-05-3106743271core:NetGoodwill2022-05-3106743271core:IntangibleAssetsOtherThanGoodwill2022-05-3106743271core:LandBuildings2022-05-3106743271core:PlantMachinery2022-05-3106743271core:Vehicles2022-05-3106743271core:FurnitureFittings2022-05-3106743271core:OfficeEquipment2022-05-3106743271core:AfterOneYear2022-05-3106743271core:WithinOneYear2022-05-3106743271core:ListedExchangeTraded2022-05-3106743271core:UnlistedNon-exchangeTraded2022-05-3106743271core:ShareCapital2022-05-3106743271core:SharePremium2022-05-3106743271core:RevaluationReserve2022-05-3106743271core:OtherReservesSubtotal2022-05-3106743271core:RetainedEarningsAccumulatedLosses2022-05-3106743271core:NetGoodwill2021-06-0106743271core:IntangibleAssetsOtherThanGoodwill2021-06-0106743271core:LandBuildings2021-06-0106743271core:PlantMachinery2021-06-0106743271core:Vehicles2021-06-0106743271core:FurnitureFittings2021-06-0106743271core:OfficeEquipment2021-06-0106743271core:AfterOneYear2021-06-0106743271core:WithinOneYear2021-06-0106743271core:ListedExchangeTraded2021-06-0106743271core:UnlistedNon-exchangeTraded2021-06-0106743271core:ShareCapital2021-06-0106743271core:SharePremium2021-06-0106743271core:RevaluationReserve2021-06-0106743271core:OtherReservesSubtotal2021-06-0106743271core:RetainedEarningsAccumulatedLosses2021-06-0106743271core:AfterOneYear2022-06-012023-05-3106743271core:WithinOneYear2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:CostValuation2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3106743271core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3106743271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3106743271core:Non-currentFinancialInstrumentscore:CostValuation2022-05-3106743271core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-05-3106743271core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-05-3106743271bus:Director12022-06-012023-05-3106743271bus:Director22022-06-012023-05-31

LIFETIME FINANCIAL THERAPY LIMITED

Registered Number
06743271
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2023

LIFETIME FINANCIAL THERAPY LIMITED
Company Information
for the year from 1 June 2022 to 31 May 2023

Directors

LEWIS, Angela Dawn
LEWIS, Owen John Rhys

Registered Address

Jamesons House
Compton Way
Witney
OX28 3AB

Place of Business

Manor Farm Barn

Westcote Barton

Chipping Norton

Oxfordshire

OX7 7AB


Registered Number

06743271 (England and Wales)
LIFETIME FINANCIAL THERAPY LIMITED
Balance Sheet as at
31 May 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets522295
22295
Current assets
Cash at bank and on hand35,13014,974
35,13014,974
Creditors amounts falling due within one year6(18,475)(13,831)
Net current assets (liabilities)16,6551,143
Total assets less current liabilities16,6771,438
Net assets16,6771,438
Capital and reserves
Called up share capital100100
Profit and loss account16,5771,338
Shareholders' funds16,6771,438
The financial statements were approved and authorised for issue by the Board of Directors on 14 September 2023, and are signed on its behalf by:
LEWIS, Owen John Rhys
Director
Registered Company No. 06743271
LIFETIME FINANCIAL THERAPY LIMITED
Notes to the Financial Statements
for the year ended 31 May 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard. The accounts have been prepared under the historical cost convention.
3.Accounting policies
Functional and presentation currency policy
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Office Equipment153
Taxation policy
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax policy
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in the accounts. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
4.Employee information

20232022
Average number of employees during the year22
5.Property, plant and equipment

Office Equipment

Total

££
Cost or valuation
At 01 June 221,9021,902
At 31 May 231,9021,902
Depreciation and impairment
At 01 June 221,6071,607
Charge for year273273
At 31 May 231,8801,880
Net book value
At 31 May 232222
At 31 May 22295295
6.Creditors within one year

2023

2022

££
Taxation and social security13,51810,723
Other creditors1,189109
Accrued liabilities and deferred income3,7682,999
Total18,47513,831